Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Fig. 3

Kaplan Meier curves for OS in type 2 T2DM and non-diabetic patients according to metabolic control based on HbA1 (a) and type of anti-diabetic treatment (b). Patients with poor metabolic control (HbA1c > 8.5%) had shorter median OS as compared with the rest of diabetic patients and nondiabetic patients. Patient receiving insulin had also worse OS compared with the rest of diabetic patients. Abbreviations: Type 2 Diabetes Mellitus (T2DM), Overall survival (OS), Glycated Haemoglobin (HbA1c)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us